APLTApplied Therapeutics, Inc.

APLT Stock Price, Valuation & Chart | Applied Therapeutics, Inc.

Compare

$0.100+0.00 (+0.00%)

At close · 02 July 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology APLT intrinsic value APLT calculated fair value vs price

Overview Financials Dividends Ratios

APLT Historical price chart

APLT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization14.86M

PE Ratio-1.03

EPS-0.1

Trading Volume0

Today's High/Low0.1/0.1

Dividend Yield0.00

52 Week High/Low1.5/0.09

Shares Outstanding144.30M

APLT Financial Statement

APLT Analyst ratings

APLT Analysis & performance metrics

APLT Company profile

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications.…

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in…

APLT Management team

Name

Position

Les D. FuntleyderCEO

Interm Chief Executive Officer, Chief Financial Officer, Principal Financial Officer & Director

Riccardo Perfetti M.D., Ph.D.

Chief Medical Officer

Constantine ChinoporosCOO

Chief Operating Officer & Chief Business Officer

Todd F. Baumgartner M.D., M.P.H.

Chief Regulatory Officer

Reena Thomas Colacot

Head of Quality

Catherine Thorpe

Interim Chief Accounting Officer

Corwin Dale Hooks

Chief Commercial Officer

John H. Johnson

Executive Chairman

Name

Position

Les D. FuntleyderCEO

Interm Chief Executive Officer, Chief Financial Officer, Principal Financial Officer & Director

Riccardo Perfetti M.D., Ph.D.

Chief Medical Officer

Constantine ChinoporosCOO

Chief Operating Officer & Chief Business Officer

Todd F. Baumgartner M.D., M.P.H.

Chief Regulatory Officer

Reena Thomas Colacot

Head of Quality

Catherine Thorpe

Interim Chief Accounting Officer

Corwin Dale Hooks

Chief Commercial Officer

John H. Johnson

Executive Chairman

Management Team

Les D. FuntleyderCEO

Interm Chief Executive Officer, Chief Financial Officer, Principal Financial Officer & Director

Riccardo Perfetti M.D., Ph.D.

Chief Medical Officer

Constantine ChinoporosCOO

Chief Operating Officer & Chief Business Officer

Todd F. Baumgartner M.D., M.P.H.

Chief Regulatory Officer

Reena Thomas Colacot

Head of Quality

Catherine Thorpe

Interim Chief Accounting Officer

Corwin Dale Hooks

Chief Commercial Officer

John H. Johnson

Executive Chairman

Management

Les D. FuntleyderCEO

Interm Chief Executive Officer, Chief Financial Officer, Principal Financial Officer & Director

Riccardo Perfetti M.D., Ph.D.

Chief Medical Officer

Constantine ChinoporosCOO

Chief Operating Officer & Chief Business Officer

Todd F. Baumgartner M.D., M.P.H.

Chief Regulatory Officer

Reena Thomas Colacot

Head of Quality

Catherine Thorpe

Interim Chief Accounting Officer

Corwin Dale Hooks

Chief Commercial Officer

John H. Johnson

Executive Chairman

Total 8 executives

APLT Frequently asked questions

What is Applied Therapeutics, Inc. (APLT) Stock Price?

Current stock price of Applied Therapeutics, Inc. (APLT) stock is $0.100. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Applied Therapeutics, Inc. (APLT) stock is 0.

Last updated at 02 July 2026, 08:00 pm.

Why is the Applied Therapeutics, Inc. (APLT) stock price going up or down today?

The stock price of Applied Therapeutics, Inc. (APLT) can change with earnings, company news, and overall market sentiment. Applied Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Applied Therapeutics, Inc. stock expensive at its current price?

Whether Applied Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for APLT on this page is -1.03. EPS on this page is -0.10. Compare those figures with peers and growth expectations before deciding if the current Applied Therapeutics, Inc. price is justified.

How has the stock price of Applied Therapeutics, Inc. (APLT) performed historically?

Historical performance for Applied Therapeutics, Inc. (APLT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how APLT reacted to past earnings and market events.

Should I buy Applied Therapeutics, Inc. (APLT) stock, at this price?

Buying Applied Therapeutics, Inc. (APLT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.